PRLD - Prelude Therapeutics GAAP EPS of -$0.42 May, 07 2024 07:46 AM Prelude Therapeutics Incorporated 2024-05-07 07:46:10 ET More on Prelude Therapeutics H.C. Wainwright cuts Prelude Therapeutics to neutral, cites valuation Seeking Alpha’s Quant Rating on Prelude Therapeutics Historical earnings data for Prelude Therapeutics Financial information for Prelude Therapeutics For further details see: Prelude Therapeutics GAAP EPS of -$0.42